BioXcel Therapeutics Ratios (2022-2025) | BTAI

Ratios Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Profitability
Gross Margin 91.97%96.22%95.63%94.31%-50.15%-89.89%86.25%94.38%-446.73%-127.32%91.67%10.83%88.78%
EBT Margin 449,600.00%2,375.16%-30,559.85%-22,826.89%-25,509.71%-11,827.57%-14,803.81%-5,947.87%-4,608.76%-1,841.03%-8,629.44%-3,868.03%-8,222.02%-16,536.67%-18,739.80%
EBIT Margin 449,714.29%2,288.02%-28,459.85%-22,224.37%-24,853.40%-11,469.15%-14,163.34%-5,285.90%-4,151.72%-1,566.67%-7,146.26%-2,866.94%-6,011.31%-13,210.00%-14,518.37%
EBITDA Margin 449,714.29%2,288.02%-28,459.85%-22,224.37%-24,853.40%-11,469.15%-14,163.34%-5,285.90%-4,151.72%-1,566.67%-7,146.26%-2,866.94%-6,011.31%-13,210.00%-14,518.37%
Operating Margin 449,714.29%2,288.02%-28,459.85%-22,224.37%-24,853.40%-11,469.15%-14,163.34%-5,285.90%-4,151.72%-1,566.67%-7,146.26%-2,866.94%-6,011.31%-13,210.00%-14,518.37%
Net Margin 449,600.00%2,375.16%-30,559.85%-22,826.89%-25,509.71%-11,827.57%-14,803.81%-5,947.87%-4,608.76%-1,841.03%-8,629.44%-3,868.03%-8,222.02%-16,536.67%-18,739.80%
FCF Margin 464,757.14%2,088.40%-22,763.50%-16,234.87%-25,414.08%-8,360.18%-11,021.70%-7,144.41%-3,042.27%-2,099.09%-7,634.58%-4,046.17%-7,168.45%-10,479.17%-19,170.41%
Efficiency
Inventory Average 1.04M1.40M1.70M1.97M1.94M1.97M2.00M2.21M2.56M2.10M1.10M0.66M0.57M0.48M
Assets Average 229.64M246.53M225.34M192.98M160.10M120.27M87.08M78.01M73.88M57.16M43.62M38.45M32.18M35.29M
Equity Average 179.14M145.62M101.88M64.89M29.43M-17.37M-48.56M-64.44M-73.33M-79.97M-89.37M-91.64M-98.92M-98.29M
Invested Capital 194.08M234.26M227.39M178.21M156.12M110.41M65.81M46.17M31.53M30.87M20.87M13.62M-84.56M-96.45M-72.10M
Asset Utilization Ratio -0.01-0.010.010.010.020.020.030.040.050.050.030.02
Leverage & Solvency
Interest Coverage Ratio -0.00M-22.88-10.54-18.11-15.21-16.08-14.85-5.79-6.70-4.67-4.04-2.60-2.53-3.75-3.25
Debt to Equity 0.000.370.721.221.8016.66-2.46-1.78-1.40-1.39-1.22-1.10-1.17-1.01-1.23
Debt Ratio 0.000.250.380.450.530.700.991.361.231.572.142.672.744.212.44
Equity Ratio 0.920.660.520.370.290.04-0.40-0.77-0.88-1.14-1.75-2.43-2.34-4.17-1.99
Times Interest Earned -0.00M-22.88-10.54-18.11-15.21-16.08-14.85-5.79-6.70-4.67-4.04-2.60-2.53-3.75-3.25
Valuation
Enterprise Value -200.44M-233.45M-232.31M-193.72M-165.52M-127.55M-89.96M-65.22M-74.14M-56.27M-40.39M-29.85M-31.01M-18.57M-37.32M
Return Ratios
Return on Sales 4,496.00%23.75%-305.60%-228.27%-255.10%-118.28%-148.04%-59.48%-46.09%-18.41%-86.29%-38.68%-82.22%-165.37%-187.40%
Return on Capital Employed -0.83%-1.09%-1.56%-2.53%-2.87%-3.11%-2.35%-2.42%-3.14%-4.12%43.17%20.16%
Return on Assets -0.73%-0.97%-1.27%-1.76%-2.06%-1.97%-1.62%-1.54%-1.83%-1.74%-2.06%-1.88%
Return on Equity -1.62%-2.87%-6.89%12.17%3.70%2.39%1.64%1.10%0.89%0.73%0.67%0.67%